Ortho Clinical Diagnostics Holdings plc provides in-vitro diagnostics solutions to the clinical laboratory and transfusion medicine communities worldwide. The company offers automated instruments; and assays, reagents, and other consumables that are used by these instruments to generate test results. Its solutions include clinical chemistry and immunoassay instruments and tests to detect and monitor disease progression across a spectrum of therapeutic areas, including COVID-19 antibody and antigen tests; and immunohematology instruments and tests for blood typing to ensure patient-donor compatibility in blood transfusions, as well as donor screening instruments and tests for blood and plasma screening for infectious diseases. The company is also involved in the provision of contract manufacturing and orthocare services. Its products are used in hospitals, laboratories, clinics, blood banks, and donor centers. Ortho Clinical Diagnostics Holdings plc was founded in 1939 and is headquartered in Raritan, New Jersey.

Ortho Clinical Diagnostics Holdings plc

QuidelOrtho specializes in diagnostic solutions, transforming diagnostic data into actionable health information. The company provides a range of products and services targeting healthcare providers and laboratory professionals.

msh id	COM:ORTHOCLINICALDIAGNOSTICS
symbol	OCDX
name	Ortho Clinical Diagnostics Holdings plc
homepage url	https://www.orthoclinicaldiagnostics.com
country	US
sector	Healthcare
industry	Medical - Diagnostics & Research
market	STOCKS
employee count	4.8K
crunchbase url	-
linkedin url	-
founders	-

market cap	-
enterprise value	-
stage	-
raised capital	-
valuation	-

monthly webtraffic	-
monthly webtraffic growth	-
growth score 14	-
growth score 28	-
growth score 90	-
growth score 365	-

revenue ltm	-
gross profit ltm	-
ebitda ltm	-
net income ltm	-
revenue ntm	-
gross profit ntm	-
ebitda ntm	-
net income ntm	-

growth cost and expenses	0.12
growth cost of revenue	0.11
growth depreciation and amortization	-0.59
growth ebitda	-0.13
growth ebitda ratio	-0.25
growth eps	-
growth eps diluted	-
growth general and administrative expenses	-
growth gross profit	0.21
growth gross profit ratio	0.04

OCDX

COM:ORTHOCLINICALDIAGNOSTICS

QuidelOrtho

Last Close

17.47

01/01 00:00

Volume Today

789.49K

Avg: -

Company Information

Market Metrics

Web & Growth Metrics

LTM & NTM Metrics

Growth & Performance Metrics

Operating Metrics

Balance Sheet Metrics

Financial Metrics (2022-2026)

cost and expenses	1.87B
cost of revenue	1.87B
depreciation and amortization	133.4M
ebitda	253.4M
ebitda ratio	0.12
eps	-0.23
eps diluted	-0.22
operating expenses	862.9M
operating income	120M
operating income ratio	0.06

accounts receivables	-
capital expenditure	-
cash at beginning of period	144.2M
cash at end of period	311.6M
inventory	305.4M
working capital ttm	433.2M

	2022	2023	2024	2025	2026
Revenue Metrics
Revenue	-	-	-	-	-
Revenue Growth	-	-	-	-	-
Revenue Multiple	-	-	-	-	-
Profit Metrics
Gross Profit	-	-	-	-	-
Gross Profit Growth	-	-	-	-	-
Gross Profit Multiple	-	-	-	-	-
EBITDA Metrics
EBITDA	-	-	-	-	-
EBITDA Growth	-	-	-	-	-
EBITDA Multiple	-	-	-	-	-
Net Income Metrics
Net Income	-	-	-	-	-
Net Income Growth	-	-	-	-	-
Net Income Multiple	-	-	-	-	-